期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

双膦酸盐类药物对种植牙患者的影响

Effects of Biosphosphonates to the Success of Dental Implant
下载PDF
导出
摘要 双膦酸类药物是目前临床上治疗骨疾病的重要药物。此药物可能引起严重并发症——颌骨坏死。口腔种植牙作为目前治疗缺牙的主要方法之一,广泛应用于口腔治疗中。而种植牙手术可能诱发双膦酸类药物相关的颌骨骨坏死。种植牙手术和双膦酸盐药物之间的相互关系值得进一步研究。 Biosphosphonates is a kind of important medicine in treating bone diseases.However,it causes serious complications named as bisphosphonate-related osteonecrosis of jaw.Dental implant which is widely used in oral treatment is an important method in treating missing teeth.However,dental implant surgery may cause the bisphosphonate-related osteonecrosis.It is extremely important to study the relationship between the effects of implant surgery on the patients and the risk of bisphosphonate-related osteonecrosis of jaw.
作者 舒小泉 Dan Rosen 刘旭桉
机构地区 美国贝尔丹生物技术有限公司
出处 《医学综述》 2009年第20期3131-3134,共4页 Medical Recapitulate
关键词 双膦酸类药物 颌骨坏死 种植牙 Bioshosphonate Osteonecrosis Dental implant
分类号 R961 [医药卫生—药理学] R782.12 [医药卫生—口腔医学]
  • 相关文献

参考文献16

  • 1Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of parnidronate in reducing skeletal events in patients with advanced multiple myeloma[ J ]. N Engl J Med, 1996,334 ( 8 ) :488-496.
  • 2Hortobagyi GN, Theriauh RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases [ J ]. N Engl J Med, 1996,335 ( 3 ) : 1785-1791.
  • 3Ruggiero SL, Mehrotra B, Rosenberg TJ. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases [ J]. J Oral Maxillofac Surg ,2004,62 ( 5 ) :527-534.
  • 4Ruggiero SL, Dodson TB, Assael LA, et al. Bisphosphonate-related osteonecrosis of the jaws [ J ]. J Oral Macillofac Surg, 2009,67 ( 5 Suppl) :2-12.
  • 5Wade ME,Suzuki JB. Osteonecrosis of the jaws and oral bisphosphonate treatment [ J ]. J Am Dent Assoc, 2006, 1372 ( 8 ) : 1115-1119.
  • 6Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management[ J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod ,2006,102 (4) :433-441.
  • 7Drake MT, Clarke BL, Khosla S. Bisphosphonates : mechanism of action and role in clinic practice [ J ]. Mayo Clin Proc,2008,83 (9) :1032-45.
  • 8Bamias A, Kastrides E,Bamia C,et al Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors[J] ,J Clin Oncol,2005,23(34) :8580-8587.
  • 9Zervas K, Vernon E, Teleioudis Z, et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma:A single-centre experience in 303 patients[ J]. Br J Hematol,2006,154 (6) :620-623.
  • 10American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy : expert panel recommendations [ J]. J Amer Dent Assoc, 2006,137 (8) :1144-1150.
医学综述
2009年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部